← SynDRA
BRD-K12244279
SynDRA canonical compound SYN0052499 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAP2K1 | MAP2K2 |
|---|
| Mechanism of action | MEK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAP2K2 INHIBITOR
- MEK inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- MEK1-2-inhibitor
- SL327 cpd
- CHEBI:92211
- RefChem:915466
- SL-327
- Benzeneacetonitrile,
- C16H12F3N3S
- A-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)-
- SCHEMBL570318
- orb1305134
- JLOXTZFYJNCPIS-UHFFFAOYSA-N
- HMS3268B07
- HMS3654M13
- AKOS030238951
- SB19419
- NCGC00092290-03
- DA-42855
- SL327
- 3-amino-3-[(4-aminophenyl)thio]-2-[2-(trifluoromethyl)phenyl]-2-propenenitrile
- alpha-{amino[(4-aminophenyl)thio]methylene}-2-(trifluoromethyl)benzeneacetonitrile
Look up BRD-K12244279 in the interactive SynDRA portal →